Expert Consensus on Clinical Diseases Responding Specifically to Traditional Chinese Medicine：Fibromyalgia Syndrome
10.13422/j.cnki.syfjx.20240797
- VernacularTitle:中医药临床优势病种探讨——纤维肌痛综合征
- Author:
Juan JIAO
1
;
Jinyang TANG
2
;
Xiujuan HOU
3
;
Mengtao LI
4
;
Dongfeng LIANG
5
;
Yuhua WANG
6
;
Weixia JING
7
;
Guangtao LI
8
;
Qin ZHANG
9
;
Yongfeng ZHANG
10
;
Guangyu LI
11
;
Qian WANG
12
;
Yang YANG
1
;
Jin HUO
13
;
Mei MO
14
;
Jihua GUO
14
;
Xiaoxiao ZHANG
14
;
Quan JIANG
1
Author Information
1. Guang'anmen Hospital，China Academy of Chinese Medical Sciences，Beijing 100053，China
2. Xiyuan Hospital of China Academy of Chinese Medical Sciences，Beijing 100091，China
3. Dongfang Hospital，Beijing University of Chinese Medicine，Beijing 100078，China
4. Peking Union Medical College Hospital，China Academy of Medical Sciences，Beijing 100730，China
5. Chinese PLA General Hospital，Beijing 100853，China
6. Beijing Shijitan Hospital，Capital Medical University，Beijing 100038，China
7. Beijing University of Chinese Medicine Third Affiliated Hospital，Beijing 100029，China
8. Peking University First Hospital，Beijing 100034，China
9. Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University，Beijing 100010，China
10. Beijing Chaoyang Hospital Affiliated to Capital Medical University，Beijing 100020，China
11. Wangjing Hospital，China Academy of Chinese Medical Sciences，Beijing 100102，China
12. Beijing Hospital，Beijing 100730，China
13. Institute of Acupuncture and Moxibustion，China；Academy of Chinese Medical Sciences，Beijing 100700，China
14. China Association of Chinese Medicine，Beijing 100029，China
- Publication Type:Journal Article
- Keywords:
disease responding specifically to a therapy;
early diagnosis;
integrated Chinese and Western medicine;
multidisciplinary joint diagnosis and treatment;
expert advice
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2024;30(1):216-222
- CountryChina
- Language:Chinese
-
Abstract:
Fibromyalgia syndrome （FMS） is a refractory， chronic non-articular rheumatic disease characterized by widespread pain throughout the body， for which there are no satisfactory therapeutic drugs or options. There are rich Chinese medical therapies， and some non-drug therapies， such as acupuncture， Tai Chi， and Ba-Duan-Jin， have shown satisfactory efficacy and safety and definite advantages of simultaneously adjusting mind and body. FMS is taken as a disease responding specifically to traditional Chinese medicine （TCM） by the National Administration of Traditional Chinese Medicine in 2018. In order to clarify the research progress in FMS and the clinical advantages of TCM/integrated Chinese and Western medicine， the China Academy of Chinese Medicine organized a seminar for nearly 20 experts in Chinese and Western medicine， including rheumatology， psychology， acupuncture and moxibustion， and encephalopathy， with the topic of difficulties in clinical diagnosis and treatment of FMS and advantages of TCM and Western medicine. The recommendations were reached on the difficulties in early diagnosis and solutions of FMS， mitigation of common non-specific symptoms， preferential analgesic therapy， TCM pathogenesis and treatment advantages， and direction of treatment with integrated Chinese and Western medicine. FMS is currently facing the triple dilemma of low early correct diagnosis， poor patient participation， and unsatisfactory benefit from pure Western medicine treatment. To solve the above problems， this paper suggests that rheumatologists should serve as the main diagnostic force of this disease， and they should improve patient participation in treatment decision-making， implement exercise therapy， and fully utilize the holistic and multidimensional features of TCM， which is effective in alleviating pain， improving mood， and decreasing adverse events. In addition， it is suggested that FMS treatment should rely on both TCM and Western medicine and adopt multidisciplinary joint treatment， which is expected to improve the standard of diagnosis and treatment of FMS in China.
